Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer(BLARCC): a Prospective, Multicenter Randomized Control Clinical Trial

NCT06709144 is registered in ClinicalTrials.gov with Haixing Ju, MD as lead sponsor.

NCT NCT06709144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06709144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer(BLARCC): a Prospective, Multicenter Randomized Control Clinical Trial
Lead sponsor
Haixing Ju, MD
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 1, 2024
Completion date
June 30, 2032
Enrollment
896 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer